a biopharmaceutical company. which focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases.
Industry Biotechnology
A.I.dvisor indicates that over the last year, MIRM has been loosely correlated with GERN. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if MIRM jumps, then GERN could also see price increases.
Ticker / NAME | Correlation To MIRM | 1D Price Change % | ||
---|---|---|---|---|
MIRM | 100% | -3.80% | ||
GERN - MIRM | 41% Loosely correlated | -1.35% | ||
CYCC - MIRM | 36% Loosely correlated | -4.91% | ||
MBIO - MIRM | 36% Loosely correlated | -3.14% | ||
GPCR - MIRM | 35% Loosely correlated | -9.34% | ||
VCYT - MIRM | 35% Loosely correlated | -2.97% | ||
More |